This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Lucky Ahmed, PhD
Posdoctoral Fellow at Boehringer Ingelheim Pharmaceuticals


Dr. Lucky Ahmed is a postdoctoral fellow at Boehringer Ingelheim Pharmaceuticals, USA.  Her current work focuses on Computational Approaches to Design of Novel Biotherapeutics. The main research interests include atomistic modeling of multi-specific T-cell engagers, sequence- and structure-based properties of antibodies and quantitative structure property relationship (QSPR) of antibodies to predict biophysical properties. Before moving to Boehringer Ingelheim, she worked as a postdoctoral research associate at Yale University. At Yale, her research focuses were mechanism action of olfactory receptors- a class of GPCR protein. She received her PhD in Computational Chemistry from Jackson State University, USA.

Agenda Sessions

  • Intrinsic Physicochemical Fingerprints of the Variable Regions of Commercially Available Antibody Based Biotherapeutic Drug Products

    On Demand
  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #3: ANTIBODY DISCOVERY AND DEVELOPABILITY - To prepare for this discussion/Q&A, attendees should view the presentations from Session #3 in the Watch On-Demand Sessions Tab prior to this session